"Cancer is not who you are, but is a journey you are facing, and we are here to care for you every step of the way while helping you maintain as much of your normal routine as possible. We are much more than a treatment center; we are a comprehensive cancer program, here to offer you education, options, and hope. You will know what your options are, why we recommend what we do, and what to expect along the way. You are our number one priority from the first day we meet you. Our goal is to meet all your treatment needs, get your strength back to where you want it to be, and empower you going forward in life."

During the past decade, Faith Regional Health Services Carson Cancer Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 17 clinical trials were completed, i.e. on average, 65.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 16 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Faith Regional Health Services Carson Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "University of Nebraska" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Faith Regional Health Services Carson Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Faith Regional Health Services Carson Cancer Center" are "Breast Cancer" (3 trials), "Recurrent Squamous Cell Lung Carcinoma" (3 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (3 trials), "Breast Carcinoma" (2 trials) and "Breast Ductal Carcinoma In Situ" (2 trials). Many other conditions were trialed in "Faith Regional Health Services Carson Cancer Center" in a lesser frequency.

Most popular intervention types in "Faith Regional Health Services Carson Cancer Center" are "Drug" (33 trials), "Other" (31 trials), "Biological" (14 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (11 trials), "Nivolumab" (6 trials), "Cisplatin" (5 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Faith Regional Health Services Carson Cancer Center" are 34 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Faith Regional Health Services Carson Cancer Center". undefined are not yet recruiting, 7 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Faith Regional Health Services Carson Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Faith Regional Health Services Carson Cancer Center, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".